Johnson & Johnson single-dose vaccine, green light in the United States – Corriere.it

Experts from the FDA, the US Food and Drug Administration, voted to recommend that the agency grant Johnson & Johnson Coronavirus Vaccine Authorization for Emergency Use. The Advisory Committee voted unanimously to recommend the vaccine for people over 18 years old. If the FDA decides on the recommendation, and it is expected to do so quickly, the vaccine will become the third licensed for use in the United States.

It will be the first single injection vaccineand what can be stored in normal refrigerators, which makes it easier to distribute than Pfizer-BioNTech and Moderna vaccines, which are milder and require two doses.

The president of the United States, Jose Biden, expressed satisfaction with the FDA’s green light for Johnson & Johnson’s coronavirus vaccine, the third to be approved in the United States, but he warned that the battle against the pandemic is far from over. This is fantastic news for all Americans, as well as an encouraging development in our efforts to end the crisis, Biden said in a statement, warning that we can’t let our guard down now or assume that victory is inevitable.

Already at the end of July, the vaccine developed by Johnson & Johnson and that today was approved by the Food and Drug Administration had shown a strong immune response. Our SARS-CoV-2 vaccine resulted in a strong antibody response and provided complete protection or almost complete with a single dose, said Paul Stoffels, MD, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, emphasizing the peculiarity of the vaccine produced by the company compared to all the others: being fully effective with just one dose .